Several studies have shown that the activation of the kynurenine (KYN) pathway in patients with depression is secondary to increased levels of the inflammatory cytokines interleukin (IL)-6, interferon (IFN)-α and tumor necrosis factor (TNF)-α [[6], [7], [8]]. This evidence concerns the gene IL6 and depressive disorder.